非编码RNA在人环素心脏毒性的作用:叙述性综述
Shudan Xiao1, Yinghui Li1, Bo Li1
1Department of Cardiovascular Surgery, The Affiliated Hospital of Qingdao University, Institute of Chronic Diseases, College of Medicine, Qingdao University, Qingdao, People's Republic of China.
Journal of inflammation research
|July 18, 2025
概括
人环素诱导的心脏毒性 (AIC) 损害了心脏. 非编码RNAs (ncRNAs) 作为生物标志物和治疗点,有望预防和治疗这种疾病.
科学领域:
- 心脏病学 心脏病学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 人环素是有效的癌症药物,但会引起心脏毒性,导致心力衰竭.
- 人环素诱导的心脏毒性 (AIC) 是一个主要问题,需要更好的诊断生物标志物.
- 非编码RNAs (ncRNAs) 调节心脏功能,并与心血管疾病有关.
研究的目的:
- 审查有关AIC的非编码RNA研究的最新进展.
- 突出ncRNAs作为AIC生物标志物和治疗点的潜力.
- 探索ncRNAs在调节心脏新陈代谢,细胞亡和AIC中的氧化应激中的作用.
主要方法:
- 在AIC.中对非编码RNA研究的文献综述.
- 对心脏过程中的ncRNA调节机制的分析.
- 检查ncRNAs作为AIC的诊断和预后指标.
主要成果:
- 非编码RNAs (lncRNAs,miRNAs,circRNAs) 是心脏新陈代谢,亡和氧化应激的关键调节者.
- ncRNAs显示出作为早期AIC检测的敏感和特定生物标志物的潜力.
- ncRNAs正在成为管理AIC和改善治疗结果的有希望的治疗点.
结论:
- 非编码RNA在AIC的发病过程中起着至关重要的作用.
- ncRNAs作为AIC的诊断和预后生物标志物具有显著的潜力.
- 向ncRNAs为新型AIC疗法和个性化癌症治疗提供了一个有前途的战略.
相关概念视频
01:23Types of RNA
Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
01:20Types of RNA
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
RNA Performs Diverse...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:25Antianginal Drugs: Calcium Channel Blockers and Ranolazine
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...